Metal Drugs and the Anticancer Immune Response
Open accessThe DOI matches its Crossref record; 1,300 of the 1,300 references it cites were found in a registry or an index.
Abstract
The immune system deploys a multitude of innate and adaptive mechanisms not only to ward off pathogens but also to prevent malignant transformation ("immune surveillance"). Hence, a clinically apparent tumor already reflects selection for those malignant cell clones capable of evading immune recognition ("immune evasion"). Metal drugs, besides their well-investigated cytotoxic anticancer effects, massively interact with the cancer-immune interface and can reverse important aspects of immune evasion. This topic has recently gained intense attention based on combination approaches with anticancer immunotherapy (e.g., immune checkpoint inhibitors), a strategy recently delivering first exciting results in clinical settings. This review summarizes the promising but still extremely fragmentary knowledge on the interplay of metal drugs with the fidelity of anticancer immune responses but also their role in adverse effects. It highlights that, at least in some cases, metal drugs can induce long-lasting anticancer immune responses. Important steps in this process comprise altered visibility and susceptibility of cancer cells toward innate and adaptive immunity, as well as direct impacts on immune cell populations and the tumor microenvironment. On the basis of the gathered information, we suggest initiating joint multidisciplinary programs to implement comprehensive immune analyses into strategies to develop novel and smart anticancer metal compounds.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The text we found for this paper looks like another document, so the self-check wasn’t run.
Citations
Cites
2 retracted
Items 401–600 of 1,300
eIF2α phosphorylation is pathognomonic for immunogenic cell death
Bezu, L., Sauvat, A., Humeau, J., Gomes-da-Silva, L. C., Iribarren, K., Forveille, S., Garcia, P., Zhao, L., Liu, P., Zitvogel, L., et al. (2018) · Cell Death & Differentiation · doi:10.1038/s41418-017-0044-9 · Cited by 241
The immune system and inflammation in breast cancer
Jiang, X., & Shapiro, D. J. (2014) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2013.06.003 · Cited by 240
HMGB1 as biomarker and drug target
Venereau, E., De Leo, F., Mezzapelle, R., Careccia, G., Musco, G., & Bianchi, M. E. (2016) · Pharmacological Research · doi:10.1016/j.phrs.2016.06.031 · Cited by 240
Stafford, W. C., Peng, X., Olofsson, M. H., Zhang, X., Luci, D. K., Lu, L., Cheng, Q., Trésaugues, L., Dexheimer, T. S., Coussens, N. P., et al. (2018) · Science Translational Medicine · doi:10.1126/scitranslmed.aaf7444 · Cited by 240
Lentz, F., Drescher, A., Lindauer, A., Henke, M., Hilger, R. A., Hartinger, C. G., Scheulen, M. E., Dittrich, C., Keppler, B. K., & Jaehde, U. (2009) · Anti-Cancer Drugs · doi:10.1097/cad.0b013e328322fbc5 · Cited by 239
Self-citationImpacts of microbiome metabolites on immune regulation and autoimmunity
Haase, S., Haghikia, A., Wilck, N., Müller, D. N., & Linker, R. A. (2018) · Immunology · doi:10.1111/imm.12933 · Cited by 239
Apoptosis and Necroptosis as Host Defense Strategies to Prevent Viral Infection
Orzalli, M. H., & Kagan, J. C. (2017) · Trends in Cell Biology · doi:10.1016/j.tcb.2017.05.007 · Cited by 238
Complexes of Ni(i): a “rare” oxidation state of growing importance
Lin, C.-Y., & Power, P. P. (2017) · Chemical Society Reviews · doi:10.1039/c7cs00216e · Cited by 238
Age‐related incidence and other epidemiological aspects of myelodysplastic syndromes
Aul, C., Gattermann, N., & Schneider, W. (1992) · British Journal of Haematology · doi:10.1111/j.1365-2141.1992.tb06430.x · Cited by 234
Cytokine-Mediated Regulation of Plasma Cell Generation: IL-21 Takes Center Stage
Moens, L., & Tangye, S. G. (2014) · Frontiers in Immunology · doi:10.3389/fimmu.2014.00065 · Cited by 234
Natural Killer T Cells in Cancer Immunotherapy
Nair, S., & Dhodapkar, M. V. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.01178 · Cited by 234
Platinum-Induced Neurotoxicity and Preventive Strategies: Past, Present, and Future
Avan, A., Postma, T. J., Ceresa, C., Avan, A., Cavaletti, G., Giovannetti, E., & Peters, G. J. (2015) · The Oncologist · doi:10.1634/theoncologist.2014-0044 · Cited by 232
Jacob, F., Novo, C. P., Bachert, C., & Van Crombruggen, K. (2013) · Purinergic Signalling · doi:10.1007/s11302-013-9357-4 · Cited by 232
Combining DNA damaging therapeutics with immunotherapy: more haste, less speed
Brown, J. S., Sundar, R., & Lopez, J. (2018) · British Journal of Cancer · doi:10.1038/bjc.2017.376 · Cited by 231
So, H., Kim, H., Lee, J.-H., Park, C., Kim, Y., Kim, E., Kim, J.-K., Yun, K.-J., Lee, K.-M., Lee, H.-Y., et al. (2007) · Journal of the Association for Research in Otolaryngology · doi:10.1007/s10162-007-0084-9 · Cited by 230
Mutational Landscape and Sensitivity to Immune Checkpoint Blockers
Chabanon, R. M., Pedrero, M., Lefebvre, C., Marabelle, A., Soria, J.-C., & Postel-Vinay, S. (2016) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-16-0903 · Cited by 230
Cell intrinsic mechanisms of T‐cell inhibition and application to cancer therapy
Peggs, K. S., Quezada, S. A., & Allison, J. P. (2008) · Immunological Reviews · doi:10.1111/j.1600-065x.2008.00649.x · Cited by 229
Colonic macrophage polarization in homeostasis, inflammation, and cancer
Isidro, R. A., & Appleyard, C. B. (2016) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00123.2016 · Cited by 229
Designing nanomedicine for immuno-oncology
Jiang, W., von Roemeling, C. A., Chen, Y., Qie, Y., Liu, X., Chen, J., & Kim, B. Y. S. (2017) · Nature Biomedical Engineering · doi:10.1038/s41551-017-0029 · Cited by 229
Thiol-Reactive Metal Compounds Inhibit NF-κB Activation by Blocking IκB Kinase
Jeon, K.-I., Jeong, J.-Y., & Jue, D.-M. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.164.11.5981 · Cited by 226
Dugbartey, G. J., Peppone, L. J., & de Graaf, I. A. M. (2016) · Toxicology · doi:10.1016/j.tox.2016.10.001 · Cited by 226
Vanadium in the detection, prevention and treatment of cancer: The in vivo evidence
Bishayee, A., Waghray, A., Patel, M. A., & Chatterjee, M. (2010) · Cancer Letters · doi:10.1016/j.canlet.2010.01.030 · Cited by 222
The contribution of satellite glial cells to chemotherapy‐induced neuropathic pain
Warwick, R. A., & Hanani, M. (2013) · European Journal of Pain · doi:10.1002/j.1532-2149.2012.00219.x · Cited by 221
Dobrovolskaia, M. A. (2015) · Journal of Controlled Release · doi:10.1016/j.jconrel.2015.08.056 · Cited by 221
Soultati, A., Mountzios, G., Avgerinou, C., Papaxoinis, G., Pectasides, D., Dimopoulos, M.-A., & Papadimitriou, C. (2012) · Cancer Treatment Reviews · doi:10.1016/j.ctrv.2011.09.002 · Cited by 221
Prasad, A. S., Beck, F. W. J., Snell, D. C., & Kucuk, O. (2009) · Nutrition and Cancer · doi:10.1080/01635580903285122 · Cited by 221
Administration of a CO-releasing molecule at the time of reperfusion reduces infarct size in vivo
Guo, Y., Stein, A. B., Wu, W.-J., Tan, W., Zhu, X., Li, Q.-H., Dawn, B., Motterlini, R., & Bolli, R. (2004) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00971.2003 · Cited by 221
Cameron, K. S., Buchner, V., & Tchounwou, P. B. (2011) · Reviews on Environmental Health · doi:10.1515/reveh.2011.012 · Cited by 219
Wani, W. A., Prashar, S., Shreaz, S., & Gómez-Ruiz, S. (2016) · Coordination Chemistry Reviews · doi:10.1016/j.ccr.2016.01.001 · Cited by 218
The Yin and Yang of copper during infection
Besold, A. N., Culbertson, E. M., & Culotta, V. C. (2016) · JBIC Journal of Biological Inorganic Chemistry · doi:10.1007/s00775-016-1335-1 · Cited by 215
7. MEDICINAL CHEMISTRY OF GOLD ANTICANCER METALLODRUGS
Casini, A., Wai-Yin Sun, R., & Ott, I. (2018) · Metallo-Drugs: Development and Action of Anticancer Agents · doi:10.1515/9783110470734-007 · Cited by 215
Type 1 regulatory T cells: a new mechanism of peripheral immune tolerance
Zeng, H., Zhang, R., Jin, B., & Chen, L. (2015) · Cellular & Molecular Immunology · doi:10.1038/cmi.2015.44 · Cited by 211
Lecomte, T., Landi, B., Beaune, P., Laurent-Puig, P., & Loriot, M.-A. (2006) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-05-2076 · Cited by 211
Verstak, B., Nagpal, K., Bottomley, S. P., Golenbock, D. T., Hertzog, P. J., & Mansell, A. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.023044 · Cited by 210
Gül, N., & van Egmond, M. (2015) · Cancer Research · doi:10.1158/0008-5472.can-15-1330 · Cited by 210
Meng, X., Leyva, M. L., Jenny, M., Gross, I., Benosman, S., Fricker, B., Harlepp, S., Hébraud, P., Boos, A., Wlosik, P., et al. (2009) · Cancer Research · doi:10.1158/0008-5472.can-08-4408 · Cited by 208
O'Day, S., Gonzalez, R., Lawson, D., Weber, R., Hutchins, L., Anderson, C., Haddad, J., Kong, S., Williams, A., & Jacobson, E. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2008.17.1579 · Cited by 208
Ott, I., Schmidt, K., Kircher, B., Schumacher, P., Wiglenda, T., & Gust, R. (2005) · Journal of Medicinal Chemistry · doi:10.1021/jm049326z · Cited by 207
The Unfolded Protein Response in Immunogenic Cell Death and Cancer Immunotherapy
Rufo, N., Garg, A. D., & Agostinis, P. (2017) · Trends in Cancer · doi:10.1016/j.trecan.2017.07.002 · Cited by 207
Apoptosis regulation in tetraploid cancer cells
Castedo, M., Coquelle, A., Vivet, S., Vitale, I., Kauffmann, A., Dessen, P., Pequignot, M. O., Casares, N., Valent, A., Mouhamad, S., et al. (2006) · The EMBO Journal · doi:10.1038/sj.emboj.7601127 · Cited by 206
Taruno, A. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19030808 · Cited by 206
Tetrathiomolybdate Inhibits Copper Trafficking Proteins Through Metal Cluster Formation
Alvarez, H. M., Xue, Y., Robinson, C. D., Canalizo-Hernández, M. A., Marvin, R. G., Kelly, R. A., Mondragón, A., Penner-Hahn, J. E., & O’Halloran, T. V. (2010) · Science · doi:10.1126/science.1179907 · Cited by 204
A Mechanistic Understanding of Axon Degeneration in Chemotherapy-Induced Peripheral Neuropathy
Fukuda, Y., Li, Y., & Segal, R. A. (2017) · Frontiers in Neuroscience · doi:10.3389/fnins.2017.00481 · Cited by 204
Sierra-Filardi, E., Vega, M. A., Sánchez-Mateos, P., Corbí, A. L., & Puig-Kröger, A. (2010) · Immunobiology · doi:10.1016/j.imbio.2010.05.020 · Cited by 203
Ecto‐calreticulin in immunogenic chemotherapy
Obeid, M., Tesniere, A., Panaretakis, T., Tufi, R., Joza, N., Van Endert, P., Ghiringhelli, F., Apetoh, L., Chaput, N., Flament, C., et al. (2007) · Immunological Reviews · doi:10.1111/j.1600-065x.2007.00567.x · Cited by 202
Vonderheide, R. H., Burg, J. M., Mick, R., Trosko, J. A., Li, D., Shaik, M. N., Tolcher, A. W., & Hamid, O. (2013) · OncoImmunology · doi:10.4161/onci.23033 · Cited by 202
Gold, the Noble Metal and the Paradoxes of its Toxicology
Merchant, B. (1998) · Biologicals · doi:10.1006/biol.1997.0123 · Cited by 202
Gd-metallofullerenol nanomaterial as non-toxic breast cancer stem cell-specific inhibitor
Liu, Y., Chen, C., Qian, P., Lu, X., Sun, B., Zhang, X., Wang, L., Gao, X., Li, H., Chen, Z., et al. (2015) · Nature Communications · doi:10.1038/ncomms6988 · Cited by 202
Nechushtan, H., Hamamreh, Y., Nidal, S., Gotfried, M., Baron, A., Shalev, Y. I., Nisman, B., Peretz, T., & Peylan-Ramu, N. (2015) · The Oncologist · doi:10.1634/theoncologist.2014-0424 · Cited by 202
Boussios, S., Pentheroudakis, G. E., Katsanos, K. H., & Pavlidis, N. A. (2012) · PubMed Central · Cited by 200
Muscle wasting: The gut microbiota as a new therapeutic target?
Bindels, L. B., & Delzenne, N. M. (2013) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2013.06.021 · Cited by 198
Liu, Y., Jiao, F., Qiu, Y., Li, W., Lao, F., Zhou, G., Sun, B., Xing, G., Dong, J., Zhao, Y., et al. (2009) · Biomaterials · doi:10.1016/j.biomaterials.2009.04.001 · Cited by 197
Salicylate reduces cisplatin nephrotoxicity by inhibition of tumor necrosis factor-α
Ramesh, G., & Reeves, W. B. (2004) · Kidney International · doi:10.1111/j.1523-1755.2004.00413.x · Cited by 196
Myeloid Colony-Stimulating Factors as Regulators of Macrophage Polarization
Hamilton, T. A., Zhao, C., Pavicic, P. G., & Datta, S. (2014) · Frontiers in Immunology · doi:10.3389/fimmu.2014.00554 · Cited by 196
Speiser, D. E., Pittet, M. J., Valmori, D., Dunbar, R., Rimoldi, D., Liénard, D., MacDonald, H. R., Cerottini, J.-C., Cerundolo, V., & Romero, P. (1999) · The Journal of Experimental Medicine · doi:10.1084/jem.190.6.775 · Cited by 196
Molecular Mechanisms and Proposed Targets for Selected Anticancer Gold Compounds
Casini, A., & Messori, L. (2011) · Current Topics in Medicinal Chemistry · doi:10.2174/156802611798040732 · Cited by 196
The role of Toll-like receptors in renal diseases
Gluba, A., Banach, M., Hannam, S., Mikhailidis, D. P., Sakowicz, A., & Rysz, J. (2010) · Nature Reviews Nephrology · doi:10.1038/nrneph.2010.16 · Cited by 195
The role of platelets in the tumor microenvironment: From solid tumors to leukemia
Yan, M., & Jurasz, P. (2016) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2015.07.008 · Cited by 194
Rhodium(III) and iridium(III) complexes as anticancer agents
Geldmacher, Y., Oleszak, M., & Sheldrick, W. S. (2012) · Inorganica Chimica Acta · doi:10.1016/j.ica.2012.06.046 · Cited by 194
Mao, Y., Poschke, I., Wennerberg, E., Pico de Coaña, Y., Egyhazi Brage, S., Schultz, I., Hansson, J., Masucci, G., Lundqvist, A., & Kiessling, R. (2013) · Cancer Research · doi:10.1158/0008-5472.can-12-4115 · Cited by 192
Colony-Stimulating Factors for the Management of Neutropenia in Cancer Patients
Dale, D. C. (2002) · Drugs · doi:10.2165/00003495-200262001-00001 · Cited by 191
Inherited Copper Transport Disorders: Biochemical Mechanisms, Diagnosis, and Treatment
Kodama, H., Fujisawa, C., & Bhadhprasit, W. (2012) · Current Drug Metabolism · doi:10.2174/138920012799320455 · Cited by 191
Khrunin, A. V., Moisseev, A., Gorbunova, V, & Limborska, S. (2010) · The Pharmacogenomics Journal · doi:10.1038/tpj.2009.45 · Cited by 190
Current state of immunotherapy for non-small cell lung cancer
Malhotra, J., Jabbour, S. K., & Aisner, J. (2007) · Translational Lung Cancer Research · doi:10.21037/tlcr.2017.03.01 · Cited by 190
Adenosine signaling and the immune system: When a lot could be too much
Antonioli, L., Fornai, M., Blandizzi, C., Pacher, P., & Haskó, G. (2019) · Immunology Letters · doi:10.1016/j.imlet.2018.04.006 · Cited by 190
The biological activity of auranofin: implications for novel treatment of diseases
Madeira, J. M., Gibson, D. L., Kean, W. F., & Klegeris, A. (2012) · Inflammopharmacology · doi:10.1007/s10787-012-0149-1 · Cited by 188
Turkson, J., Zhang, S., Palmer, J., Kay, H., Stanko, J., Mora, L. B., Sebti, S., Yu, H., & Jove, R. (2004) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.1533.3.12 · Cited by 188
Mechanisms of chemotherapy-induced behavioral toxicities
Vichaya, E. G., Chiu, G. S., Krukowski, K., Lacourt, T. E., Kavelaars, A., Dantzer, R., Heijnen, C. J., & Walker, A. K. (2015) · Frontiers in Neuroscience · doi:10.3389/fnins.2015.00131 · Cited by 187
Tran, L., Allen, C. T., Xiao, R., Moore, E., Davis, R., Park, S.-J., Spielbauer, K., Van Waes, C., & Schmitt, N. C. (2017) · Cancer Immunology Research · doi:10.1158/2326-6066.cir-17-0235 · Cited by 186
Shen, S., Li, H.-J., Chen, K.-G., Wang, Y.-C., Yang, X.-Z., Lian, Z.-X., Du, J.-Z., & Wang, J. (2017) · Nano Letters · doi:10.1021/acs.nanolett.7b01193 · Cited by 186
Induction of Immunogenic Cell Death by Chemotherapeutic Platinum Complexes
Wong, D. Y. Q., Ong, W. W. F., & Ang, W. H. (2015) · Angewandte Chemie International Edition · doi:10.1002/anie.201500934 · Cited by 185
Integration of Innate Immune Signaling
Thaiss, C. A., Levy, M., Itav, S., & Elinav, E. (2016) · Trends in Immunology · doi:10.1016/j.it.2015.12.003 · Cited by 185
Bruno, A., Ferlazzo, G., Albini, A., & Noonan, D. M. (2014) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/dju200 · Cited by 184
Phase II trial of tetrathiomolybdate in patients with advanced kidney cancer.
Redman, B. G., Esper, P., Pan, Q., Dunn, R. L., Hussain, H. K., Chenevert, T. L., Brewer, G. J., & Merajver, S. D. (2003) · PubMed · Cited by 184
Pharmacological control of lung metastases of solid tumours by a novel ruthenium complex
Sava, G., Capozzi, I., Clerici, K., Gagliardi, G., Alessio, E., & Mestroni, G. (1998) · Clinical & Experimental Metastasis · doi:10.1023/a:1006521715400 · Cited by 183
Cisplatin-Induced Ototoxicity: Effects, Mechanisms and Protection Strategies
Callejo, A., Sedó-Cabezón, L., Juan, I., & Llorens, J. (2015) · Toxics · doi:10.3390/toxics3030268 · Cited by 183
Chen, S.-J., Zhou, G.-B., Zhang, X.-W., Mao, J.-H., de Thé, H., & Chen, Z. (2011) · Blood · doi:10.1182/blood-2010-11-283598 · Cited by 183
Effects of conventional therapeutic interventions on the number and function of regulatory T cells
Roselli, M., Cereda, V., di Bari, M. G., Formica, V., Spila, A., Jochems, C., Farsaci, B., Donahue, R., Gulley, J. L., Schlom, J., et al. (2013) · OncoImmunology · doi:10.4161/onci.27025 · Cited by 182
A Pathophysiologic Role for T Lymphocytes in Murine Acute Cisplatin Nephrotoxicity
Liu, M., Chien, C.-C., Burne-Taney, M., Molls, R. R., Racusen, L. C., Colvin, R. B., & Rabb, H. (2006) · Journal of the American Society of Nephrology · doi:10.1681/asn.2005010102 · Cited by 182
A comprehensive survey of the mutagenic impact of common cancer cytotoxics
Szikriszt, B., Póti, Á., Pipek, O., Krzystanek, M., Kanu, N., Molnár, J., Ribli, D., Szeltner, Z., Tusnády, G. E., Csabai, I., et al. (2016) · Genome Biology · doi:10.1186/s13059-016-0963-7 · Cited by 181
Wallington, M., Saxon, E. B., Bomb, M., Smittenaar, R., Wickenden, M., McPhail, S., Rashbass, J., Chao, D., Dewar, J., Talbot, D., et al. (2016) · The Lancet Oncology · doi:10.1016/s1470-2045(16)30383-7 · Cited by 181
Friedberg, J. W., Neuberg, D., Stone, R. M., Alyea, E., Jallow, H., LaCasce, A., Mauch, P. M., Gribben, J. G., Ritz, J., Nadler, L. M., et al. (1999) · Journal of Clinical Oncology · doi:10.1200/jco.1999.17.10.3128 · Cited by 180
Kim, S. Y., Choi, Y. J., Joung, S. M., Lee, B. H., Jung, Y., & Lee, J. Y. (2010) · Immunology · doi:10.1111/j.1365-2567.2009.03203.x · Cited by 178
Platinum Antitumor Complexes: 50 Years Since Barnett Rosenberg's Discovery
Muggia, F. M., Bonetti, A., Hoeschele, J. D., Rozencweig, M., & Howell, S. B. (2015) · Journal of Clinical Oncology · doi:10.1200/jco.2015.60.7481 · Cited by 177
PUMA amplifies necroptosis signaling by activating cytosolic DNA sensors
Chen, D., Tong, J., Yang, L., Wei, L., Stolz, D. B., Yu, J., Zhang, J., & Zhang, L. (2018) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1717190115 · Cited by 177
Immune-mediated processes implicated in chemotherapy-induced peripheral neuropathy
Lees, J. G., Makker, P. G. S., Tonkin, R. S., Abdulla, M., Park, S. B., Goldstein, D., & Moalem-Taylor, G. (2017) · European Journal of Cancer · doi:10.1016/j.ejca.2016.12.006 · Cited by 176
Yao, Y., Yuan, D., Liu, H., Gu, X., & Song, Y. (2013) · Cancer Immunology, Immunotherapy · doi:10.1007/s00262-012-1347-9 · Cited by 175
Multi-receptor detection of individual bacterial products by the innate immune system
Kieser, K. J., & Kagan, J. C. (2017) · Nature Reviews Immunology · doi:10.1038/nri.2017.25 · Cited by 175
Johnsen, A. K., Templeton, D. J., Sy, M.-S., & Harding, C. V. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.163.8.4224 · Cited by 173
New insights in Au-NHCs complexes as anticancer agents
Porchia, M., Pellei, M., Marinelli, M., Tisato, F., Del Bello, F., & Santini, C. (2018) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2018.01.065 · Cited by 173
Development of anticancer agents: wizardry with osmium
Hanif, M., Babak, M. V., & Hartinger, C. G. (2014) · Drug Discovery Today · doi:10.1016/j.drudis.2014.06.016 · Cited by 172
Mirabelli, C. K., Hill, D. T., Faucette, L. F., McCabe, F. L., Girard, G. R., Bryan, D. B., Sutton, B. M., Barus, J. O. L., Crooke, S. T., & Johnson, R. K. (1987) · Journal of Medicinal Chemistry · doi:10.1021/jm00395a004 · Cited by 172
Transcriptional regulation of antigen presentation
van den Elsen, P. J., Holling, T. M., Kuipers, H. F., & van der Stoep, N. (2004) · Current Opinion in Immunology · doi:10.1016/j.coi.2003.11.015 · Cited by 172
Deuis, J. R., Zimmermann, K., Romanovsky, A. A., Possani, L. D., Cabot, P. J., Lewis, R. J., & Vetter, I. (2013) · Pain · doi:10.1016/j.pain.2013.05.032 · Cited by 171
Manegold, C., Gravenor, D., Woytowitz, D., Mezger, J., Hirsh, V., Albert, G., Al-Adhami, M., Readett, D., Krieg, A. M., & Leichman, C. G. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2007.12.5807 · Cited by 171
Metal complexes as potential modulators of inflammatory and autoimmune responses
Leung, C., Lin, S., Zhong, H., & Ma, D. (2014) · Chemical Science · doi:10.1039/c4sc03094j · Cited by 171
HMGB1 Activates Proinflammatory Signaling via TLR5 Leading to Allodynia
Das, N., Dewan, V., Grace, P. M., Gunn, R. J., Tamura, R., Tzarum, N., Watkins, L. R., Wilson, I. A., & Yin, H. H. (2016) · Cell Reports · doi:10.1016/j.celrep.2016.09.076 · Cited by 171
Molecular Mechanisms of Nickel Allergy
Saito, M., Arakaki, R., Yamada, A., Tsunematsu, T., Kudo, Y., & Ishimaru, N. (2016) · International Journal of Molecular Sciences · doi:10.3390/ijms17020202 · Cited by 170
Lv, L. L., Tang, P. M.-K., Li, C. J., You, Y. K., Li, J., Huang, X.-R., Ni, J., Feng, M., Liu, B. C., & Lan, H.-Y. (2017) · Kidney International · doi:10.1016/j.kint.2016.10.020 · Cited by 170
Gold compound auranofin inhibits IκB kinase (IKK) by modifying Cys-179 of IKKβ subunit
Jeon, K.-I., Byun, M.-S., & Jue, D.-M. (2003) · Experimental & Molecular Medicine · doi:10.1038/emm.2003.9 · Cited by 169
N -Heterocyclic Carbene Metal Complexes as Bio-Organometallic Antimicrobial and Anticancer Drugs
Patil, S. A., Patil, S. A., Patil, R., Keri, R. S., Budagumpi, S., Balakrishna, G. R., & Tacke, M. (2015) · Future Medicinal Chemistry · doi:10.4155/fmc.15.61 · Cited by 169
Glial role in oxaliplatin-induced neuropathic pain
Di Cesare Mannelli, L., Pacini, A., Micheli, L., Tani, A., Zanardelli, M., & Ghelardini, C. (2014) · Experimental Neurology · doi:10.1016/j.expneurol.2014.06.016 · Cited by 168
Copper deficiency as an anti-cancer strategy.
Goodman, V. L., Brewer, G. J., & Merajver, S. D. (2004) · Endocrine-related cancer · doi:10.1677/erc.0.0110255 · Cited by 168
Urso, E., & Maffia, M. (2015) · Journal of Vascular Research · doi:10.1159/000438485 · Cited by 167
HMGB1: The Central Cytokine for All Lymphoid Cells
Li, G., Liang, X., & Lotze, M. T. (2013) · Frontiers in Immunology · doi:10.3389/fimmu.2013.00068 · Cited by 166
Anti-cancer potential of gold complexes
Tiekink, E. R. T. (2008) · Inflammopharmacology · doi:10.1007/s10787-007-0018-5 · Cited by 166
Kanterman, J., Sade-Feldman, M., Biton, M., Ish-Shalom, E., Lasry, A., Goldshtein, A., Hubert, A., & Baniyash, M. (2014) · Cancer Research · doi:10.1158/0008-5472.can-14-0657 · Cited by 166
Kaur, T., Zamani, D., Tong, L., Rubel, E. W., Ohlemiller, K. K., Hirose, K., & Warchol, M. E. (2015) · Journal of Neuroscience · doi:10.1523/jneurosci.2325-15.2015 · Cited by 166
Increasing Intracellular Bioavailable Copper Selectively Targets Prostate Cancer Cells
Cater, M. A., Pearson, H. B., Wolyniec, K., Klaver, P., Bilandzic, M., Paterson, B. M., Bush, A. I., Humbert, P. O., La Fontaine, S., Donnelly, P. S., et al. (2013) · ACS Chemical Biology · doi:10.1021/cb400198p · Cited by 165
Platinum-induced neurotoxicity: A review of possible mechanisms
Kanat, O., Ertas, H., & Caner, B. (2017) · World Journal of Clinical Oncology · doi:10.5306/wjco.v8.i4.329 · Cited by 165
Rhodium and its compounds as potential agents in cancer treatment
Katsaros, N., & Anagnostopoulou, A. (2002) · Critical Reviews in Oncology/Hematology · doi:10.1016/s1040-8428(01)00222-0 · Cited by 165
Cabrera, C. M., Jiménez, P., Cabrera, T., Esparza, C., Ruiz‐Cabello, F., & Garrido, F. (2003) · Tissue Antigens · doi:10.1034/j.1399-0039.2003.00020.x · Cited by 164
Awuah, S. G., Zheng, Y.-R., Bruno, P. M., Hemann, M. T., & Lippard, S. J. (2015) · Journal of the American Chemical Society · doi:10.1021/jacs.5b10182 · Cited by 164
Baras, A. S., Drake, C., Liu, J.-J., Gandhi, N., Kates, M., Hoque, M. O., Meeker, A., Hahn, N., Taube, J. M., Schoenberg, M. P., et al. (2016) · OncoImmunology · doi:10.1080/2162402x.2015.1134412 · Cited by 164
Iron induces anti-tumor activity in tumor-associated macrophages
Costa da Silva, M., Breckwoldt, M. O., Vinchi, F., Correia, M. P., Stojanovic, A., Thielmann, C. M., Meister, M., Muley, T., Warth, A., Platten, M., et al. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.01479 · Cited by 164
Huang, L., Xu, H., & Peng, G. (2018) · Cellular & Molecular Immunology · doi:10.1038/cmi.2018.4 · Cited by 164
Ward, Y., Lake, R., Faraji, F., Sperger, J., Martin, P., Gilliard, C., Ku, K. P., Rodems, T., Niles, D., Tillman, H., et al. (2018) · Cell Reports · doi:10.1016/j.celrep.2018.03.092 · Cited by 164
Beyond symptomatic relief for chemotherapy‐induced peripheral neuropathy: Targeting the source
Ma, J., Kavelaars, A., Dougherty, P. M., & Heijnen, C. J. (2018) · Cancer · doi:10.1002/cncr.31248 · Cited by 164
The metabolism of inorganic arsenic oxides, gallium arsenide, and arsine: a toxicochemical review
Carter, D. E., Aposhian, H. V., & Gandolfi, A. J. (2003) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2003.07.009 · Cited by 163
Gold Nanoparticle Reprograms Pancreatic Tumor Microenvironment and Inhibits Tumor Growth
Saha, S., Xiong, X., Chakraborty, P. K., Shameer, K., Arvizo, R. R., Kudgus, R. A., Dwivedi, S. K. D., Hossen, M. N., Gillies, E. M., Robertson, J. D., et al. (2016) · ACS Nano · doi:10.1021/acsnano.6b02231 · Cited by 163
Olivares-Navarrete, R., Hyzy, S. L., Slosar, P. J., Schneider, J. M., Schwartz, Z., & Boyan, B. D. (2015) · Spine · doi:10.1097/brs.0000000000000778 · Cited by 162
Regulation of HMGB1 release by inflammasomes
Lu, B., Wang, H., Andersson, U., & Tracey, K. J. (2013) · Protein & Cell · doi:10.1007/s13238-012-2118-2 · Cited by 161
Josting, A., Wiedenmann, S., Franklin, J., May, M., Sieber, M., Wolf, J., Engert, A., & Diehl, V. (2003) · Journal of Clinical Oncology · doi:10.1200/jco.2003.07.160 · Cited by 161
Renal Dendritic Cells Ameliorate Nephrotoxic Acute Kidney Injury
Tadagavadi, R. K., & Reeves, W. B. (2009) · Journal of the American Society of Nephrology · doi:10.1681/asn.2009040407 · Cited by 161
Platinum compounds in children with cancer: toxicity and clinical management
Ruggiero, A., Trombatore, G., Triarico, S., Arena, R., Ferrara, P., Scalzone, M., Pierri, F., & Riccardi, R. (2013) · Anti-Cancer Drugs · doi:10.1097/cad.0b013e3283650bda · Cited by 160
Cisplatin-Associated Ototoxicity: A Review for the Health Professional
Paken, J., Govender, C. D., Pillay, M., & Sewram, V. (2016) · Journal of Toxicology · doi:10.1155/2016/1809394 · Cited by 160
Lheureux, S., Butler, M. O., Clarke, B., Cristea, M. C., Martin, L. P., Tonkin, K., Fleming, G. F., Tinker, A. V., Hirte, H. W., Tsoref, D., et al. (2018) · JAMA Oncology · doi:10.1001/jamaoncol.2017.3776 · Cited by 160
Myeloid cell heterogeneity in cancer: not a single cell alike
Kiss, M., Van Gassen, S., Movahedi, K., Saeys, Y., & Laoui, D. (2018) · Cellular Immunology · doi:10.1016/j.cellimm.2018.02.008 · Cited by 159
Role of LFA-1 and ICAM-1 in Cancer
Reina, M., & Espel, E. (2017) · Cancers · doi:10.3390/cancers9110153 · Cited by 159
Tseng, C.-W., Hung, C.-F., Alvarez, R. D., Trimble, C., Huh, W. K., Kim, D., Chuang, C.-M., Lin, C.-T., Tsai, Y.-C., He, L., et al. (2008) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-08-0037 · Cited by 158
Dose-Dense Chemotherapy Improves Mechanisms of Antitumor Immune Response
Chang, C.-L., Hsu, Y.-T., Wu, C.-C., Lai, Y.-Z., Wang, C., Yang, Y.-C., Wu, T.-C., & Hung, C.-F. (2013) · Cancer Research · doi:10.1158/0008-5472.can-12-2225 · Cited by 158
Bradley, S. D., Chen, Z., Melendez, B., Talukder, A., Khalili, J. S., Rodriguez-Cruz, T., Liu, S., Whittington, M., Deng, W., Li, F., et al. (2015) · Cancer Immunology Research · doi:10.1158/2326-6066.cir-15-0030 · Cited by 157
Burris, H. A., Bakewell, S., Bendell, J. C., Infante, J., Jones, S. F., Spigel, D. R., Weiss, G. J., Ramanathan, R. K., Ogden, A., & Von Hoff, D. (2016) · ESMO Open · doi:10.1136/esmoopen-2016-000154 · Cited by 157
Tanaka, H., Matsushima, H., Mizumoto, N., & Takashima, A. (2009) · Cancer Research · doi:10.1158/0008-5472.can-09-1101 · Cited by 157
Selection and fine-tuning of the autoimmune T-cell repertoire
Anderton, S. M., & Wraith, D. C. (2002) · Nature reviews. Immunology · doi:10.1038/nri842 · Cited by 156
Kopera, E., Schwerdtle, T., Hartwig, A., & Bal, W. (2004) · Chemical Research in Toxicology · doi:10.1021/tx049842s · Cited by 155
Roles of neutrophils in cancer growth and progression
Galdiero, M. R., Varricchi, G., Loffredo, S., Mantovani, A., & Marone, G. (2018) · Journal of Leukocyte Biology · doi:10.1002/jlb.3mr0717-292r · Cited by 155
Inhibition of the DNA‐binding activity of NF‐κB by gold compounds in vitro
Yang, J.-P., Merin, J. P., Nakano, T., Kato, T., Kitade, Y., & Okamoto, T. (1995) · FEBS Letters · doi:10.1016/0014-5793(95)00157-5 · Cited by 154
Novel Approaches to Exploiting Invariant NKT Cells in Cancer Immunotherapy
Wolf, B. J., Choi, J. E., & Exley, M. A. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.00384 · Cited by 152
Castration-Resistant Prostate Cancer: From New Pathophysiology to New Treatment
Sridhar, S. S., Freedland, S. J., Gleave, M. E., Higano, C. S., Mulders, P., Parker, C. C., Sartor, O. A., & Fred Saad, C. (2013) · European Urology · doi:10.1016/j.eururo.2013.08.008 · Cited by 152
Anticancer metal drugs and immunogenic cell death
Terenzi, A., Pirker, C., Keppler, B. K., & Berger, W. (2016) · Journal of Inorganic Biochemistry · doi:10.1016/j.jinorgbio.2016.06.021 · Cited by 151
Self-citationHypermutated tumours in the era of immunotherapy: The paradigm of personalised medicine
Nebot-Bral, L., Brandão, D., Verlingue, L., Rouleau, É., Caron, O., Despras, E., Dakdouki, Y. E., Champiat, S., Aoufouchi, S., Leary, A. F., et al. (2017) · European Journal of Cancer · doi:10.1016/j.ejca.2017.07.026 · Cited by 151
Mutational patterns in chemotherapy resistant muscle-invasive bladder cancer
Liu, D., Abbosh, P., Keliher, D., Reardon, B., Miao, D., Mouw, K., Weiner-Taylor, A., Wankowicz, S., Han, G., Teo, M. Y., et al. (2017) · Nature Communications · doi:10.1038/s41467-017-02320-7 · Cited by 151
Protein kinase C in the immune system: from signalling to chromatin regulation
Lim, P. S., Sutton, C. R., & Rao, S. (2015) · Immunology · doi:10.1111/imm.12510 · Cited by 150
Transition Metal Based Anticancer Drugs
Garbutcheon‐Singh, K. B., Grant, M. P., Harper, B. W. J., Krause‐Heuer, A. M., Manohar, M., Orkey, N., & Aldrich-Wright, J. R. (2011) · Current Topics in Medicinal Chemistry · doi:10.2174/156802611794785226 · Cited by 150
Interactions of nanomaterials with the immune system
Hussain, S., Vanoirbeek, J. A. J., & Hoet, P. H. M. (2012) · WIREs Nanomedicine and Nanobiotechnology · doi:10.1002/wnan.166 · Cited by 149
Drug–gut microbiota interactions: implications for neuropharmacology
Walsh, J., Griffin, B. T., Clarke, G., & Hyland, N. P. (2018) · British Journal of Pharmacology · doi:10.1111/bph.14366 · Cited by 149
Gebremeskel, S., & Johnston, B. (2015) · Oncotarget · doi:10.18632/oncotarget.6113 · Cited by 149
Breast Cancer Stem Cell Potent Copper(II)–Non‐Steroidal Anti‐Inflammatory Drug Complexes
Boodram, J. N., Mcgregor, I. J., Bruno, P. M., Cressey, P., Hemann, M. T., & Suntharalingam, K. (2016) · Angewandte Chemie International Edition · doi:10.1002/anie.201510443 · Cited by 149
16. Copper Complexes in Cancer Therapy
Denoyer, D., Clatworthy, S. A. S., & Cater, M. A. (2018) · De Gruyter eBooks · doi:10.1515/9783110470734-022 · Cited by 148
Chemoradiation Increases PD-L1 Expression in Certain Melanoma and Glioblastoma Cells
Derer, A., Spiljar, M., Bäumler, M., Hecht, M., Fietkau, R., Frey, B., & Gaipl, U. S. (2016) · Frontiers in Immunology · doi:10.3389/fimmu.2016.00610 · Cited by 148
Mukherjea, D., Jajoo, S., Whitworth, C. A., Bunch, J. R., Turner, J. G., Rybak, L. P., & Ramkumar, V. (2008) · Journal of Neuroscience · doi:10.1523/jneurosci.1307-08.2008 · Cited by 147
Ridnour, L. A., Cheng, R. Y. S., Switzer, C. H., Heinecke, J. L., Ambs, S., Glynn, S., Young, H. A., Trinchieri, G., & Wink, D. A. (2013) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-12-0408 · Cited by 147
Li, H., Hu, J., Wu, S., Wang, L., Cao, X., Zhang, X., Dai, B., Cao, M., Shao, R., Zhang, R., et al. (2016) · Oncotarget · doi:10.18632/oncotarget.6516 · Cited by 147
So, H., Kim, H., Kim, Y., Kim, E., Pae, H., Chung, H., Kim, H. J., Kwon, K., Lee, K., Lee, H.-Y., et al. (2008) · Journal of the Association for Research in Otolaryngology · doi:10.1007/s10162-008-0126-y · Cited by 146
Liu, H., Zhang, T., Jin, Y., Li, H., Huang, J., Li, X., Wu, B., Huang, X., & Hou, J. (2012) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-012-1231-7 · Cited by 146
Kaur, T., Mukherjea, D., Sheehan, K., Jajoo, S., Rybak, L. P., & Ramkumar, V (2011) · Cell Death & Disease · doi:10.1038/cddis.2011.63 · Cited by 146
Beneficial bacteria inhibit cachexia
Varian, B. J., Goureshetti, S., Poutahidis, T., Lakritz, J. R., Levkovich, T., Kwok, C., Teliousis, K., Ibrahim, Y. M., Mirabal, S., & Erdman, S. E. (2016) · Oncotarget · doi:10.18632/oncotarget.7730 · Cited by 146
Changes in macrophage phenotype as the immune response evolves
Lichtnekert, J., Kawakami, T., Parks, W. C., & Duffield, J. S. (2013) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2013.05.013 · Cited by 145
Pahonțu, E., Julea, F., Roşu, T., Purcărea, V. L., Chumakov, Y., Petrenco, P., & Gulea, A. (2015) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.12508 · Cited by 145
Protective Effect of Carbon Monoxide–Releasing Compounds in Ischemia-Induced Acute Renal Failure
Vera, T., Henegar, J. R., Drummond, H. A., Rimoldi, J. M., & Stec, D. E. (2005) · Journal of the American Society of Nephrology · doi:10.1681/asn.2004090736 · Cited by 145
Lesterhuis, W. J., Salmons, J., Nowak, A. K., Rozali, E. N., Khong, A., Dick, I. M., Harken, J. A., Robinson, B. W., & Lake, R. A. (2013) · PLoS ONE · doi:10.1371/journal.pone.0061895 · Cited by 145
Enteric nervous system manifestations of neurodegenerative disease
Chalazonitis, A., & Rao, M. (2018) · Brain Research · doi:10.1016/j.brainres.2018.01.011 · Cited by 145
Perniola, R. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.00098 · Cited by 145
[Gd@C82(OH)22]n Nanoparticles Induce Dendritic Cell Maturation and Activate Th1 Immune Responses
Yang, D., Zhao, Y., Guo, H., Li, Y., Tewary, P., Xing, G., Hou, W., Oppenheim, J. J., & Zhang, N. (2010) · ACS Nano · doi:10.1021/nn901478z · Cited by 144
Nanoscale artificial antigen presenting cells for T cell immunotherapy
Perica, K., De León Medero, A., Durai, M., Chiu, Y. L., Bieler, J. G., Sibener, L., Niemöller, M., Assenmacher, M., Richter, A., Edidin, M., et al. (2014) · Nanomedicine: Nanotechnology, Biology and Medicine · doi:10.1016/j.nano.2013.06.015 · Cited by 144
Mukherjea, D., Jajoo, S., Kaur, T., Sheehan, K. E., Ramkumar, V., & Rybak, L. P. (2010) · Antioxidants and Redox Signaling · doi:10.1089/ars.2010.3110 · Cited by 144
Perspectives for Vanadium in Health Issues
Rehder, D. (2016) · Future Medicinal Chemistry · doi:10.4155/fmc.15.187 · Cited by 144
Metal allergens nickel and cobalt facilitate TLR4 homodimerization independently of MD2
Raghavan, B., Martin, S. F., Esser, P. R., Goebeler, M., & Schmidt, M. (2012) · EMBO Reports · doi:10.1038/embor.2012.155 · Cited by 143
Janes, K., Wahlman, C., Little, J. W., Doyle, T. M., Tosh, D. K., Jacobson, K. A., & Salvemini, D. (2014) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2014.08.010 · Cited by 143
Metallomics insights into the programmed cell death induced by metal-based anticancer compounds
Tan, C., Lu, Y., Ji, L., & Mao, Z. (2014) · Metallomics · doi:10.1039/c3mt00225j · Cited by 143
From Vanadis to Atropos: vanadium compounds as pharmacological tools in cell death signalling
Morinville, A., Maysinger, D., & Shaver, A. G. (1998) · Trends in Pharmacological Sciences · doi:10.1016/s0165-6147(98)01257-7 · Cited by 143
Kang, K. P., KIM, D., Jung, Y., Lee, A., Lee, S.-W., Lee, S. Y., Jang, K. Y., Sung, M. J., Park, S. K., & Kim, W. K. (2009) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfp242 · Cited by 142
Arsenic trioxide: insights into its evolution to an anticancer agent
Hoonjan, M., Jadhav, V., & Bhatt, P. (2018) · JBIC Journal of Biological Inorganic Chemistry · doi:10.1007/s00775-018-1537-9 · Cited by 142
Babak, M. V., Meier, S. M., Huber, K., Reynisson, J., Legin, A. A., Jakupec, M. A., Roller, A., Stukalov, A., Gridling, M., Bennett, K. L., et al. (2015) · Chemical Science · doi:10.1039/c4sc03905j · Cited by 141
Self-citationChitambar, C. R. (2016) · Pharmacological Research · doi:10.1016/j.phrs.2016.11.009 · Cited by 141
Fritzsching, B., Fellenberg, J., Moskovszky, L., Sápi, Z., Krenacs, T., Machado, I., Poeschl, J., Lehner, B., Szendrõi, M., Bosch, A. L., et al. (2015) · OncoImmunology · doi:10.4161/2162402x.2014.990800 · Cited by 140
Inhibition of endothelial cell functions and of angiogenesis by the metastasis inhibitor NAMI-A
Vacca, A., Bruno, M., Boccarelli, A., Coluccia, M., Ribatti, D., Bergamo, A., Garbisa, S., Sartor, L., & Sava, G. (2002) · British Journal of Cancer · doi:10.1038/sj.bjc.6600176 · Cited by 140
Human Natural Killer Cells: Origin, Receptors, Function, and Clinical Applications
Moretta, L., Montaldo, E., Vacca, P., Del Zotto, G., Moretta, F., Merli, P., Locatelli, F., & Mingari, M. C. (2014) · International Archives of Allergy and Immunology · doi:10.1159/000365632 · Cited by 140
Blood-labyrinth barrier and fluid dynamics of the inner ear.
Juhn, S. K., Hunter, B. A., & Odland, R. M. (2001) · PubMed · Cited by 140
Stress-induced cellular responses in immunogenic cell death: Implications for cancer immunotherapy
Radogna, F., & Diederich, M. (2018) · Biochemical Pharmacology · doi:10.1016/j.bcp.2018.02.006 · Cited by 140
Differential Regulation of TLR-Dependent MyD88 and TRIF Signaling Pathways by Free Zinc Ions
Brieger, A., Rink, L., & Haase, H. (2013) · The Journal of Immunology · doi:10.4049/jimmunol.1301261 · Cited by 139
Pan, Q., Bao, L., & Merajver, S. D. (2003) · PubMed · Cited by 139
Human Macrophages Constitute Targets for Immunotoxic Inorganic Arsenic
Lemarie, A., Morzadec, C., Bourdonnay, E., Fardel, O., & Vernhet, L. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.177.5.3019 · Cited by 138
B cell-regulated immune responses in tumor models and cancer patients
Fremd, C., Schuetz, F., Sohn, C., Beckhove, P., & Domschke, C. (2013) · OncoImmunology · doi:10.4161/onci.25443 · Cited by 138
Ganesan, A.-P., Johansson, M., Ruffell, B., Beltran, A., Lau, J., Jablons, D. M., & Coussens, L. M. (2013) · The Journal of Immunology · doi:10.4049/jimmunol.1301317 · Cited by 138
Analysis of T-cell proliferation and cytokine secretion in the individuals exposed to arsenic
Biswas, R., Ghosh, P., Banerjee, N., Das, J., Sau, T., Banerjee, A., Roy, S., Ganguly, S., Chatterjee, M., Mukherjee, A., et al. (2008) · Human & Experimental Toxicology · doi:10.1177/0960327108094607 · Cited by 138
Chemotherapy and immunotherapy: mapping the road ahead
Cook, A., Lesterhuis, W. J., Nowak, A. K., & Lake, R. (2015) · Current Opinion in Immunology · doi:10.1016/j.coi.2015.12.003 · Cited by 138
Mouse B7-H3 induces antitumor immunity
Sun, X., Vale, M., Leung, E. Y., Kanwar, J. R., Gupta, R., & Krissansen, G. W. (2003) · Gene Therapy · doi:10.1038/sj.gt.3302070 · Cited by 137
Long-Term Complications of Chemotherapy for Germ Cell Tumours
Chaudhary, U. B., & Haldas, J. (2003) · Drugs · doi:10.2165/00003495-200363150-00004 · Cited by 137
Park, K. C., Fouani, L., Jansson, P. J., Wooi, D., Sahni, S., Lane, D. J. R., Palanimuthu, D., Lok, H. C., Kovačević, Z., Huang, M. L. H., et al. (2016) · Metallomics · doi:10.1039/c6mt00105j · Cited by 137
The Contribution of Immune Infiltrates to Ototoxicity and Cochlear Hair Cell Loss
Wood, M. B., & Zuo, J. (2017) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2017.00106 · Cited by 137
Cerboni, C., Fionda, C., Soriani, A., Zingoni, A., Doria, M., Cippitelli, M., & Santoni, A. (2014) · Frontiers in Immunology · doi:10.3389/fimmu.2013.00508 · Cited by 136
Tumor Eradication by Cisplatin Is Sustained by CD80/86-Mediated Costimulation of CD8+ T Cells
Beyranvand Nejad, E., van der Sluis, T. C., van Duikeren, S., Yagita, H., Janssen, G. M., van Veelen, P. A., Melief, C. J. M., van der Burg, S. H., & Arens, R. (2016) · Cancer Research · doi:10.1158/0008-5472.can-16-0881 · Cited by 136
Beyond platinums: gold complexes as anticancer agents.
Nardon, C., Boscutti, G., & Fregona, D. (2014) · PubMed · Cited by 136
Mitochondrial Electron Transport Is the Cellular Target of the Oncology Drug Elesclomol
Blackman, R. K., Cheung-Ong, K., Gebbia, M., Proia, D. A., He, S., Kepros, J., Jonneaux, A., Marchetti, P., Kluza, J., Rao, P. E., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0029798 · Cited by 135
Flocke, L. S., Trondl, R., Jakupec, M. A., & Keppler, B. K. (2016) · Investigational New Drugs · doi:10.1007/s10637-016-0337-8 · Cited by 135
Self-citationZou, T., Lok, C., Fung, Y. M. E., & Che, C. (2013) · Chemical Communications · doi:10.1039/c3cc40953h · Cited by 135
Handel, M. L., Watts, C. K., deFazio, A., Day, R. O., & Sutherland, R. L. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.10.4497 · Cited by 133
Inflammasomes and Cancer: The Dynamic Role of the Inflammasome in Tumor Development
Kantono, M., & Guo, B. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.01132 · Cited by 133
Research works printed but not linked: 47
- van der Most R. G., 2005, Discovery Medicine, 5, 265
- Alberts B., 2015, Mol. Biol. Cell
- Seliger B., 1996, Exp. Hematol., 24, 1275
- Fink D., 1996, Cancer Res., 56, 4881
- Yoshikawa A., 1997, Kobe J. Med. Sci., 43, 109
- 10.1007/s00775-018- 1546-8 · doi:10.1007/s00775-018-
- Rosenberg, B. In Advances in Antimicrobial and Antineoplastic Chemotherapy, University Park Press: Baltimore, 1972; Vol. 11.
- 10.1002/(SICI)1098-2264(199704)18:4<286::AID-GCC6>3.0.CO;2-X · doi:10.1002/(sici)1098-2264(199704)18:4<286::aid-gcc6>3.0.co;2-x
- Dempsey J. L., 1985, Cancer Res., 45, 2873
- Nio Y., 2000, Anticancer Res., 20, 3293
- Qin X., 2010, Cell. Mol. Biol. (Noisy- le-grand), 56, 1366
- Kleinerman E. S., 1980, Cancer Res., 40, 3099
- Lichtenstein A. K., 1986, Cancer Res., 46, 639
- 10.1002/1097-0142(19930215)71:4<1313::AID-CNCR2820710424>3.0.CO;2-# · doi:10.1002/1097-0142(19930215)71:4<1313::aid-cncr2820710424>3.0.co;2-#
- Yamaue H., 1991, J. Clin. Lab. Immunol., 35, 165
- 10.1002/(SICI)1097-0215(19971104)73:3<416::AID-IJC17>3.0.CO;2-A · doi:10.1002/(sici)1097-0215(19971104)73:3<416::aid-ijc17>3.0.co;2-a
- Jiang J., 2006, Anticancer Res., 26, 2237
- Ujiie T., 1989, Jpn. J. Exp. Med., 59, 17
- Maeda K., 2011, Anticancer Res., 31, 4569
- Miller W. H., 2002, Cancer Res., 62, 3893
- 10.1097/CJI.0b013e3181755deb · DOI
- Kreuser E. D., 1992, Semin. Oncol., 19, 73
- Magnarin M., 2000, Anticancer Res., 20, 2939
- Nardon C., 2014, Anticancer Res., 34, 487
- Hashimoto K., 1994, J. Rheumatol., 21, 1020
- Yan A., 1990, J. Rheumatol., 17, 47
- Wang X. D., 2009, Zhongguo Shi Yan Xue Ye Xue Za Zhi, 17, 533
- 10.1371/journal.pone.0100933 · DOI · Paper page
- Korbecki J., 2012, Acta Biochim. Polym., 59, 195
- 10.3109/1547691X.2014.996681 · DOI
- Desoize B., 2004, Anticancer Res., 24, 1529
- Sava G., 1985, Anticancer Res., 5, 249
- Boscolo P., 2004, Ann. Clin. Lab. Sci., 34, 299
- Brewer G. J., 2000, Clin. Cancer Res., 6, 1
- Redman B. G., 2003, Clin. Cancer Res., 9, 1666
- Pan Q., 2003, Mol. Cancer Res., 1, 701
- Lukasewycz O. A., 1982, J. Natl. Cancer Inst., 69, 489
- 10.1515/9783110470734-016 · doi:10.1515/9783110470734-016
- Eriksson M., 2009, Anticancer Res., 29, 11
- Signat B., 2011, Curr. Issues Mol. Biol., 13, 25
- Sonis S. T., 2004, J. Support. Oncol., 2, 21
- 10.1053/sonc.2002.35524 · doi:10.1053/sonc.2002.35524 · Paper page
- Juhn S. K., 2001, Int. Tinnitus J., 7, 72
- Boussios S., 2012, Ann. Gastroenterol., 25, 106
- Takeyama K., 2000, Int. J. Hematol., 71, 144
- Giles F. J., 1994, Curr. Opin. Hematol., 1, 256
- Lu J., 2017, Ochsner J., 17, 379
Cited by
Metallodrugs are unique: opportunities and challenges of discovery and development
Anthony, E. J., Bolitho, E. M., Bridgewater, H. E., Carter, O. W. L., Donnelly, J. M., Imberti, C., Lant, E. C., Lermyte, F., Needham, R. J., Palau, M., et al. (2020) · Chemical Science · doi:10.1039/d0sc04082g · Cited by 692
Toxicity of gold nanoparticles (AuNPs): A review
Sani, A., Cao, C., & Cui, D. (2021) · Biochemistry and Biophysics Reports · doi:10.1016/j.bbrep.2021.100991 · Cited by 454
Classification of Metal-Based Drugs according to Their Mechanisms of Action
Boros, E., Dyson, P. J., & Gasser, G. (2020) · Chem · doi:10.1016/j.chempr.2019.10.013 · Cited by 437
New Designs for Phototherapeutic Transition Metal Complexes
Imberti, C., Zhang, P., Huang, H., & Sadler, P. J. (2020) · Angewandte Chemie International Edition · doi:10.1002/anie.201905171 · Cited by 443
The immune microenvironment in cartilage injury and repair
Li, M., Yin, H., Yan, Z., Li, H., Wu, J., Wang, Y., Wei, F., Tian, G., Ning, C., Li, H., et al. (2022) · Acta Biomaterialia · doi:10.1016/j.actbio.2021.12.006 · Cited by 403
Metadata
- Authors
- Englinger, B., Pirker, C., Heffeter, P., Terenzi, A., Kowol, C. R., Keppler, B. K., & Berger, W.
- Affiliations
- Comprehensive Cancer Center Vienna (AT)
- University of Vienna (AT)
- Corresponding author
- Berger, Walter
- ORCID
- Venue
- Chemical Reviews
- Publisher
- American Chemical Society (ACS)
- Published
- 2018-11-29
- Volume
- 119
- Issue
- 2
- Pages
- 1519-1624
- ISSN
- 0009-2665 (ISSN-L)
- 1520-6890
- OpenAlex
- W2903051221
- Cited by
- 355
- References
- 1,298
- Citations by year
- 2026: 28 · 2025: 44 · 2024: 47 · 2023: 51 · 2022: 49 · 2021: 45 · 2020: 53 · 2019: 38
- FWCI
- 3.56
- Type
- journal article
- Language
- en
- Open access
- green
- hdl.handle.net
- Licence
- other-oa
- Locations
- Chemical Reviews (publishedVersion)
- PubMed (publishedVersion)
- Nova Science Publishers (Nova Science Publishers, Inc.) (submittedVersion, other-oa)
- Funders
- FP7 People: Marie-Curie Actions (609431)
- Universit?t Wien
- Medizinische Universit?t Wien
- Johanna Mahlke, geb. Obermann-Stiftung zur F?rderung der Krebsforschung an der Universit?t Wien
- Topics
- Health Sciences › Medicine › Oncology › Cancer Immunotherapy and Biomarkers
- Life Sciences › Immunology and Microbiology › Immunology › Immunotherapy and Immune Responses
- Health Sciences › Medicine › Oncology › Metal complexes synthesis and properties
- Keywords
- metal-based anticancer agents, antitumor immunity, immune surveillance, immune evasion, cancer immunotherapy, immune checkpoint inhibitors, tumor microenvironment, innate and adaptive immunity
- MeSH terms
- Gastrointestinal Microbiome, Antineoplastic Agents, Humans, Immunity, Innate, Immunotherapy, Lymphocytes, Metals, Neoplasms, Nanoparticles, Coordination Complexes
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.